Any serious treatment-emergent adverse event |
2/35 (5.71) |
4/36 (11.11) |
Any nonserious treatment-emergent adverse event |
35/35 (100.00) |
33/36 (91.67) |
Death |
0 |
0 |
Discontinuation of treatment because of a treatment-emergent adverse event |
0 |
0 |
Serious treatment-emergent adverse events |
Treated |
Placebo |
Total participants affected by serious adverse events |
2/35 (5.71) |
4/36 (11.11) |
Surgical and medical procedures |
|
|
Hysterectomy |
1/35 (2.86) |
0/36 (0) |
Thyroidectomy |
0/35 (0) |
1/36 (2.78) |
Nervous system disorders |
|
|
Multiple sclerosis relapse with hospital admission |
0/35 (0) |
1/36 (2.78) |
Brain hypoxia due to cardiac arrest |
0/35 (0) |
1/36 (2.78) |
Pregnancy |
0/35 (0) |
1/36 (2.78) |
Skin disorders |
|
|
Allergy to synthetic fabric |
0/35 (0) |
1/36 (2.78) |
Back pain |
0/35 (0) |
2/36 (5.56) |
Diabetes |
1/35 (2.86) |
0/36 (0) |
Common treatment-emergent nonserious adverse events affecting ≥5% of patients |
|
|
Gastrointestinal tract disorders |
|
|
Diarrhea |
9/35 (25.71) |
9/36 (25.00) |
Abdominal discomfort |
8/35 (22.86) |
6/36 (16.67) |
Gastroenteritis |
4/35 (11.43) |
5/36 (13.89) |
Constipation |
1/35 (2.86) |
3/36 (8.33) |
Nausea |
3/35 (8.57) |
0/36 (0.00) |
Urinary tract infection |
7/35 (20.00) |
6/36 (16.67) |
Respiratory |
|
|
Upper tract infections |
16/35 (45.71) |
18/36 (50.00) |
Nasopharyngitis |
3/35 (8.57) |
2/36 (5.56) |
Lower tract infections |
3/35 (8.57) |
3/36 (8.33) |
Cough |
2/35 (5.71) |
2/36 (5.56) |
Chest pain |
2/35 (5.71) |
0/36 (0.00) |
Nervous system |
|
|
Headache |
1/35 (2.86) |
6/36 (16.67) |
Dizziness |
0/35 (0) |
2/36 (5.56) |
Depression |
2/35 (5.71) |
1/36 (2.78) |
Skin |
|
|
Reaction at plaster site |
29/35 (82.86) |
10/36 (27.78) |
Rash |
3/35 (8.57) |
3/36 (8.33) |
Pain of skin |
1/35 (2.86) |
2/36 (5.56) |
Musculoskeletal |
|
|
Pain in extremity |
2/35 (5.71) |
7/36 (19.44) |
Back pain |
3/35 (8.57) |
2/36 (5.56) |
Other |
|
|
Ear infection |
0/35 (0) |
3/36 (8.33) |
Tooth abscess |
3/35 (8.57) |
3/36 (8.33) |
Hay fever |
1/35 (2.86) |
3/36 (8.33) |